Dynavax Technologies | Capital Ordinaire



Ordinary Share Capital Changement Date
AbbVie USD 18M 0 2024-12
Adma Biologics USD 24K 0 2024-12
Amgen USD 538M 33.04B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Dynavax Technologies USD 117.23M 117.11M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
TG Therapeutics USD 158.02M 157.87M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Dynavax Technologies Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.